Machine learning and directed evolution improved an L-Dopa-producing monooxygenase
Zero-shot protein models prioritized HpaBC substitutions, which were experimentally assayed with a L-Dopa-responsive GFP biosensor. EVOLVEpro then combined experimentally validated substitutions, including directed-evolution-derived variants, and selected higher-order designs. The best reported combined variants produced up to 57–58 times the wild-type fluorescence signal under the stated assay conditions. This is a biosensor proxy for L-Dopa production, not a purified-enzyme kinetic measurement; the work also builds on prior directed-evolution mutations and does not establish clinical benefit.
Technology: MutCompute, ProteinMPNN, ESM protein language models and EVOLVEpro combinatorial design
Family ESM / ESMFold: profile · models page
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Preprint
- Test type: direct test
- Tested: 329 model-predicted variants were assayed; 19 showed at least 1.25-fold biosensor signal. EVOLVEpro-selected combined variants yielded up to 57–58-fold normalized fluorescence relative to wild type under the reported assay conditions.
- Still unknown: Fluorescence from a DopA/GFP biosensor is an indirect L-Dopa-production proxy, not a purified-enzyme catalytic constant. The work includes directed-evolution-derived mutations; G295T had prior directed-evolution support. No human therapeutic efficacy is established.
- AI role: MutCompute, ProteinMPNN and ESM prioritized single substitutions for experimental testing; EVOLVEpro combined tested mutations and iteratively selected higher-order variants, including designs incorporating directed-evolution results.
Evidence sources: https://api.biorxiv.org/details/biorxiv/10.64898/2026.07.31.742090 · https://www.biorxiv.org/content/10.64898/2026.07.31.742090v1.full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 17 Nov 2026. Review scope: Primary bioRxiv v1 API metadata and Crossref posted-date metadata checked; primary v1 full-text indexed extract reviewed for methods, biosensor-normalized outcomes, model role and affiliation. Direct full-text page open was blocked..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.